Filippo Severin

621 total citations
20 papers, 298 citations indexed

About

Filippo Severin is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Filippo Severin has authored 20 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 15 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Filippo Severin's work include Chronic Lymphocytic Leukemia Research (15 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Filippo Severin is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Filippo Severin collaborates with scholars based in Italy, Germany and United States. Filippo Severin's co-authors include Livio Trentin, Federica Frezzato, Andrea Visentin, Gianpietro Semenzato, Monica Facco, Valentina Trimarco, Veronica Martini, Francesco Piazza, Flavia Raggi and Anna Maria Brunati and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Filippo Severin

18 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Filippo Severin Italy 12 159 132 99 74 54 20 298
Gedeon Loules Greece 11 123 0.8× 82 0.6× 164 1.7× 49 0.7× 92 1.7× 14 383
Man Chun John United States 10 58 0.4× 103 0.8× 69 0.7× 116 1.6× 146 2.7× 19 285
Giovanna Bosshard Switzerland 11 66 0.4× 95 0.7× 102 1.0× 172 2.3× 128 2.4× 15 401
Sara Bolin United States 10 90 0.6× 225 1.7× 135 1.4× 16 0.2× 70 1.3× 13 411
Ken-ichi Sawada Japan 9 81 0.5× 214 1.6× 88 0.9× 55 0.7× 74 1.4× 9 396
Kirsi J. Granberg Finland 12 123 0.8× 255 1.9× 48 0.5× 24 0.3× 68 1.3× 18 386
Patricia S. Hähnel Germany 10 53 0.3× 297 2.3× 69 0.7× 64 0.9× 152 2.8× 13 513
Billy Michael Chelliah Jebaraj Germany 10 173 1.1× 117 0.9× 75 0.8× 99 1.3× 49 0.9× 19 300
Alessandra Trojani Italy 8 257 1.6× 85 0.6× 134 1.4× 227 3.1× 52 1.0× 17 373
Kathrin T. Doepfner Switzerland 6 51 0.3× 230 1.7× 37 0.4× 32 0.4× 34 0.6× 8 304

Countries citing papers authored by Filippo Severin

Since Specialization
Citations

This map shows the geographic impact of Filippo Severin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Severin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Severin more than expected).

Fields of papers citing papers by Filippo Severin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Severin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Severin. The network helps show where Filippo Severin may publish in the future.

Co-authorship network of co-authors of Filippo Severin

This figure shows the co-authorship network connecting the top 25 collaborators of Filippo Severin. A scholar is included among the top collaborators of Filippo Severin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo Severin. Filippo Severin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Severin, Filippo, et al.. (2025). HSPA8 and HSPA9: Two prognostic and therapeutic targets in breast, colon, and kidney cancers?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(6). 167827–167827.
2.
Rossin, Federica, et al.. (2024). The Role of Transglutaminase 2 in Cancer: An Update. International Journal of Molecular Sciences. 25(5). 2797–2797. 17 indexed citations
3.
Severin, Filippo, Andrea Visentin, Elisa Pagnin, et al.. (2023). Focal adhesion kinase activation by calcium‐dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness. British Journal of Haematology. 203(2). 224–236. 5 indexed citations
4.
Severin, Filippo, et al.. (2023). Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?. Biomolecules. 13(4). 604–604. 11 indexed citations
5.
Severin, Filippo, Andrea Urbani, Tatiana Varanita, et al.. (2022). Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model. Journal of Experimental & Clinical Cancer Research. 41(1). 64–64. 23 indexed citations
6.
Frezzato, Federica, Andrea Visentin, Filippo Severin, et al.. (2021). Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia. Cancers. 13(21). 5453–5453. 6 indexed citations
7.
Visentin, Andrea, Federica Frezzato, Filippo Severin, et al.. (2020). <p>Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia</p>. OncoTargets and Therapy. Volume 13. 9679–9688. 19 indexed citations
8.
Visentin, Andrea, Monica Facco, Carmela Gurrieri, et al.. (2019). Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments. Clinical Lymphoma Myeloma & Leukemia. 19(10). 678–685.e4. 22 indexed citations
9.
Frezzato, Federica, Flavia Raggi, Veronica Martini, et al.. (2019). HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia. International Journal of Cancer. 145(11). 3089–3100. 31 indexed citations
10.
Severin, Filippo, Federica Frezzato, Andrea Visentin, et al.. (2019). In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment. Cancers. 11(12). 1939–1939. 39 indexed citations
11.
Martini, Veronica, Federica Frezzato, Filippo Severin, et al.. (2018). Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia. Oncotarget. 9(63). 32219–32231. 7 indexed citations
12.
Severin, Filippo, Federica Frezzato, Veronica Martini, et al.. (2018). Three Different Jak2/Stat3-Related Pathways Favor the Survival of Chronic Lymphocytic Leukemia Neoplastic Clone. Blood. 132(Supplement 1). 4405–4405. 1 indexed citations
13.
Visentin, Andrea, Francesca Romana Mauro, Silvia Imbergamo, et al.. (2018). Protective Role Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia: FOCUS on Subcutaneous Immunoglobulin Formulations. Blood. 132(Supplement 1). 4954–4954. 2 indexed citations
14.
Martini, Veronica, Cristina Gattazzo, Federica Frezzato, et al.. (2017). Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. British Journal of Haematology. 178(1). 81–93. 24 indexed citations
15.
Visentin, Andrea, Silvia Imbergamo, Carmela Gurrieri, et al.. (2016). Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients. European Journal of Cancer. 72. 103–111. 17 indexed citations
16.
Martini, Veronica, Federica Frezzato, Valentina Trimarco, et al.. (2016). Cortactin Is a New Player in Aggressiveness and Diffusion of Chronic Lymphocytic Leukaemia. Blood. 128(22). 4353–4353.
17.
Severin, Filippo, Federica Frezzato, Veronica Martini, et al.. (2016). Inhibition of JAK2/STAT3 Pathway Leads to Apoptosis in Chronic Lymphocytic Leukemia Cells. Blood. 128(22). 2023–2023. 2 indexed citations
18.
Frezzato, Federica, Benedetta Accordi, Valentina Trimarco, et al.. (2016). Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins. Journal of Leukocyte Biology. 100(5). 1061–1070. 13 indexed citations
19.
Visentin, Andrea, Monica Facco, Federica Frezzato, et al.. (2015). Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 15(10). 612–620.e5. 21 indexed citations
20.
Trimarco, Valentina, Elisa Ave, Monica Facco, et al.. (2015). Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival. Oncotarget. 6(39). 42130–42149. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gedeon Loules Breakdown of academic impact, for papers by Man Chun John Breakdown of academic impact, for papers by Giovanna Bosshard Breakdown of academic impact, for papers by Sara Bolin Breakdown of academic impact, for papers by Ken-ichi Sawada Breakdown of academic impact, for papers by Kirsi J. Granberg Breakdown of academic impact, for papers by Patricia S. Hähnel Breakdown of academic impact, for papers by Billy Michael Chelliah Jebaraj Breakdown of academic impact, for papers by Alessandra Trojani Breakdown of academic impact, for papers by Kathrin T. Doepfner
Rankless by CCL
2026